HomeFeatures › Laser Surgery Planning
Core Module

EVERY SAFE SURGERY BEGINS WITH A VERIFIED PLAN.

Written by the RLES AI clinical rules team · Medically reviewed by Alim Hüseynov, MD · Berrin Toksü, MD · Ercüment Bozkurt, MD · Last updated: 18 August 2026

RLES AI plans all six refractive laser procedures — SMILE, LASIK, iLASIK, Q-LASIK, PRK and T-PRK — testing every plan against procedure-specific safety floors and the published nomograms of your own devices, and returns a signature-ready PDF report in minutes.

THE TISSUE BUDGET, DONE PROPERLY

Every plan is built on three independent pillars: PTA (percent tissue altered)[1] with a Kmax-dependent ceiling — the steeper the cornea, the tighter the limit; RSB (residual stromal bed) with floors specific to each procedure family, because LASIK, lenticule extraction and surface ablation do not share the same biomechanics; and RCT (residual corneal thickness), controlled independently of the flap, because no blade choice can repair an RCT violation — only reducing ablation can. Residual bed thickness, pre-operative corneal thickness, patient age and topographic abnormality are all factors in published ectasia risk models.[2]

  • Measured ablation-depth tables per optical zone — not just the Munnerlyn approximation[3]
  • Optical-zone alternatives presented with their trade-offs, so the surgeon sees the cost of every choice
  • Flap and cap thickness menus restricted to what the registered device can actually cut

POST-OP KERATOMETRY — THE FORGOTTEN LIMIT

Tissue can be sufficient while the optics are not. RLES AI estimates the expected post-operative keratometry per meridian and applies a Min–Max K planning window. Keratometry outside this range has been associated with reduced optical quality and may increase the risk of unfavourable visual outcomes — excessive flattening with optical degradation and ocular-surface symptoms, excessive steepening with a topographic picture that can resemble keratoconus. From this window the system computes the maximum treatable correction of every individual cornea — a number most planning software never shows.

YOUR DEVICES, YOUR NOMOGRAMS

Register your excimer laser, microkeratome or femtosecond platform once. From then on every plan applies that device's published tables — ring and vacuum selection, blade options, ablation-zone geometry — and values are never substituted from another machine. Missing data is never assumed normal: the report names exactly what is missing.

WHAT THE REPORT CONTAINS
Patient & procedure summary · tissue budget per eye · post-op K prediction · ectasia risk analysis · device nomogram recommendations · hinge planning · what remains to be completed — ready for the surgeon's signature.

FREQUENTLY ASKED QUESTIONS

Which procedures does RLES AI plan?
All six refractive laser procedures — SMILE, LASIK, iLASIK, Q-LASIK, PRK and T-PRK — each tested against its own PTA, RSB and RCT safety floors and the published nomogram of the registered device.
Does RLES AI replace the surgeon’s judgment?
No. It is clinical decision support: it grades risk, shows every calculation and its source, and the final clinical decision always rests with the surgeon.
SEE IT ON YOUR OWN CASES.
RLES AI runs as a mobile interface on your phone — nothing to install from a store, reports in minutes. The final clinical decision always rests with the surgeon.

Request Information
References — peer-reviewed sources
  1. Santhiago MR et al. Association between the percent tissue altered and post-LASIK ectasia in eyes with normal preoperative topography. Am J Ophthalmol 2014;158:87-95. PMID: 24992564
  2. Randleman JB et al. Risk assessment for ectasia after corneal refractive surgery. Ophthalmology 2008;115:37-50. PMID: 18083221
  3. Celik U, Bozkurt E, Celik B, Demirok A, Yilmaz OF. Pain, wound healing and refractive comparison of mechanical and transepithelial debridement in photorefractive keratectomy for myopia: results of 1 year follow-up. Cont Lens Anterior Eye. 2014;37(6):420-6. doi:10.1016/j.clae.2014.07.001 PMID: 25081522
Sources open on PubMed in a new tab.